New hope for back pain sufferers: JHG002 therapy under study

NCT ID NCT07304076

Recruiting now Symptom relief Sponsor: Jaseng Medical Foundation Source: ClinicalTrials.gov ↗

First seen Jan 11, 2026 · Last updated May 10, 2026 · Updated 24 times

Summary

This study tests a treatment called JHG002 for people with chronic low back pain lasting 6 months or more. About 96 adults aged 19 to 69 with moderate to severe pain will receive the therapy. The main goal is to see if it reduces pain intensity after 6 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Bucheon Jaseng Hospital of Korean Medicine
RECRUITING

Bucheon-si, GGyeonggi-do, 14598, South Korea

Contact Phone: •••-•••-•••• Email: •••••@•••••
Dongguk University Bundang Oriental Hospital
RECRUITING

Seongnam, GGyeonggi-do, 13601, South Korea

Contact Phone: •••-•••-•••• Email: •••••@•••••
Jaseng Hospital of Korean Medicine
RECRUITING

Seoul, Gangnam-Gu, 06110, South Korea

Contact Phone: •••-•••-•••• Email: •••••@•••••
Kyung Hee University Korean Medicine Hospital at Gangdong
RECRUITING

Seoul, Gangdong-gu, 05278, South Korea

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

CHRONIC LOW BACK PAIN (CLBP)